Present and future role of combination treatment in hypertension

Journal of Cardiovascular Pharmacology

Volumn 31, Issue SUPPL. 2, 1998, Pages

  Mancia, Giuseppe ^a   Failla, Monica ^a   Grappiolo, Alessandra ^a   Giannattasio, Cristina ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Combination therapy; Hypertension; Mechanisms of action; Patient compliance

Indexed keywords

DRUG COMBINATION; HUMAN; HYPERTENSION; PATIENT COMPLIANCE; REVIEW;

DRUG THERAPY, COMBINATION; HUMANS; HYPERTENSION; PATIENT COMPLIANCE;

EID: 0031627211     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199800002-00007     Document Type: Article

References (20)

1. Mancia G, Grassi G. Combination treatment in antihypertensive drug trial [Editorial]. Cardiovasc Drugs Ther 1997;11:517-8.
2. Fifth Report of a Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1993;153:154-93.
3. 1993 Guidelines for the management of mild hypertension: memorandum from a World Health Organization/International Society of Hypertension meeting. J Hypertens 1993;11:905-18.
4. Sever P. The heterogeneity of hypertension: why doesn't every patient respond to every antihypertensive drug? J Hum Hypertens 1995;9:S33-6.
5. Mancia G, Mangoni AA, Failla M, Rivolta MR. Guidelines for the treatment of hypertension: a commentary. Curr Ther Res 1996;57: 3-15.
6. Mancia G. Improving the management of hypertension in clinical practice. J Hum Hypertens 1995;9(suppl 2):S29-31.
7. Hoelscher DD, Weir MR, Bakris GL. Hypertension in diabetic patients: an update of interventional studies to preserve renal function. J Clin Pharmacol 1995;35:73-80.
8. Lusher TF, Wenzel RR, Morean P, Takase H. Vascular protective effects of ACE-inhibitors and calcium-antagonists: theoretical basis for a combination therapy in hypertension and other cardiovascular diseases. Cardiovasc Drug Ther 1995;9(suppl 3):509-23.
9. Mancia G, Omboni S, Ravogli A. Effects of verapamil, trandolapril and their fixed combination on 24 h blood pressure: VeraTran Study. Am J Hypertens 1997;10:492-9.
10. Mancia G, Omboni S, Parati G, Ravogli A, Villam A, Zanchetti A. Lack of placebo effect on ambulatory blood pressure. 1995;8:311-15.
11. Mancia G, Sega R, Milesi C, Cesana G, Zanchetti A. Blood pressure control in hypertensive population. Lancet 1997;349:454-7.
12. Logan AG, Irvine MJ. Compliance, labelling and hypertension. In: Swalls JD, ed. Textbook of hypertension. Oxford: Blackwell Scientific, 1994:1267-82.
13. Greenberg RN. Overview of patient compliance with medication dosing: a literature review. Clin Ther 1984;6:592-9.
14. Swain MA, Steckel SB. Influencing advance among hypertensives. Res Nurs Health 1981;4:267-80.
15. Isles CG, Wolker LM, Beevers GD. Mortality in patients of the Glasgow blood pressure clinic. J Hypertens 1986;4:141-56.
16. Lindholm L, Eyertsson G, Shersten B. High risk of mortality in well treated male hypertensives. A retrospective study of 40-59 year old hypertensives in a Swedish primary care district. Acta Med Scand 1984;216:251-9.
17. Mancia G, Grassi G. Considerations on current and future trials in hypertension. Blood Pressure 1996;5:327-32.
18. Collins R, Peto R, MacMahon S. Blood pressure, stroke and coronary heart disease. Part 2. Short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990;35:827-38.
19. Kannel WB, McGel D, Gordon T. A general cardiovascular risk profile in the Framingham Study. Am J Cardiol 1976;38:46-51.
20. The HOT Study Group. The Hypertension Optimal Treatment Study (the Hot Study). Blood Pressure 1993;2:62-8.